441 related articles for article (PubMed ID: 26898111)
1. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity.
Casellas R; Basu U; Yewdell WT; Chaudhuri J; Robbiani DF; Di Noia JM
Nat Rev Immunol; 2016 Mar; 16(3):164-76. PubMed ID: 26898111
[TBL] [Abstract][Full Text] [Related]
2. AID Biology: A pathological and clinical perspective.
Choudhary M; Tamrakar A; Singh AK; Jain M; Jaiswal A; Kodgire P
Int Rev Immunol; 2018 Jan; 37(1):37-56. PubMed ID: 28933967
[TBL] [Abstract][Full Text] [Related]
3. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
Pérez-Durán P; de Yebenes VG; Ramiro AR
Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
[TBL] [Abstract][Full Text] [Related]
5. Role of AID in tumorigenesis.
Okazaki IM; Kotani A; Honjo T
Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
[TBL] [Abstract][Full Text] [Related]
6. Activation-induced deaminase: light and dark sides.
de Yébenes VG; Ramiro AR
Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
[TBL] [Abstract][Full Text] [Related]
7. The role of activation-induced cytidine deaminase in lymphomagenesis.
Gu X; Shivarov V; Strout MP
Curr Opin Hematol; 2012 Jul; 19(4):292-8. PubMed ID: 22517589
[TBL] [Abstract][Full Text] [Related]
8. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
[TBL] [Abstract][Full Text] [Related]
9. Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
Sernández IV; de Yébenes VG; Dorsett Y; Ramiro AR
PLoS One; 2008; 3(12):e3927. PubMed ID: 19079594
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.
Compagno M; Wang Q; Pighi C; Cheong TC; Meng FL; Poggio T; Yeap LS; Karaca E; Blasco RB; Langellotto F; Ambrogio C; Voena C; Wiestner A; Kasar SN; Brown JR; Sun J; Wu CJ; Gostissa M; Alt FW; Chiarle R
Nature; 2017 Feb; 542(7642):489-493. PubMed ID: 28199309
[TBL] [Abstract][Full Text] [Related]
11. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies.
Luo Z; Ronai D; Scharff MD
J Allergy Clin Immunol; 2004 Oct; 114(4):726-35; quiz 736. PubMed ID: 15480307
[TBL] [Abstract][Full Text] [Related]
12. Biological function of activation-induced cytidine deaminase (AID).
Kumar R; DiMenna LJ; Chaudhuri J; Evans T
Biomed J; 2014; 37(5):269-83. PubMed ID: 25163501
[TBL] [Abstract][Full Text] [Related]
13. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.
Robbiani DF; Bunting S; Feldhahn N; Bothmer A; Camps J; Deroubaix S; McBride KM; Klein IA; Stone G; Eisenreich TR; Ried T; Nussenzweig A; Nussenzweig MC
Mol Cell; 2009 Nov; 36(4):631-41. PubMed ID: 19941823
[TBL] [Abstract][Full Text] [Related]
14. Pillars Article: Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme.
Muramatsu M; Kinoshita K; Fagarasan S; Yamada S; Shinkai Y; Honjo T
J Immunol; 2018 Nov; 201(9):2530-2540. PubMed ID: 30348658
[No Abstract] [Full Text] [Related]
15. The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene Diversification.
Leeman-Neill RJ; Lim J; Basu U
J Immunol; 2018 Nov; 201(9):2527-2529. PubMed ID: 30348657
[No Abstract] [Full Text] [Related]
16. Molecular mechanism of immunoglobulin V-region diversification regulated by transcription and RNA metabolism in antigen-driven B cells.
Sakaguchi N; Maeda K; Kuwahara K
Scand J Immunol; 2011 Jun; 73(6):520-6. PubMed ID: 21388430
[TBL] [Abstract][Full Text] [Related]
17. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
[TBL] [Abstract][Full Text] [Related]
18. AID targeting in antibody diversity.
Pavri R; Nussenzweig MC
Adv Immunol; 2011; 110():1-26. PubMed ID: 21762814
[TBL] [Abstract][Full Text] [Related]
19. Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
Casellas R; Yamane A; Kovalchuk AL; Potter M
Immunology; 2009 Mar; 126(3):316-28. PubMed ID: 19302140
[TBL] [Abstract][Full Text] [Related]
20. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
